Corticosteroid utilization and risk of infections among rheumatoid arthritis patients taking biologic and non-biologic disease modifying antirheumatic drugs

dc.creatorElham Rahme
dc.creatorHacene Nedjar
dc.creatorLouis Bessette
dc.creatorFrancisco de Assis Acurcio
dc.date.accessioned2022-10-19T01:01:51Z
dc.date.accessioned2023-06-16T16:13:53Z
dc.date.available2022-10-19T01:01:51Z
dc.date.available2023-06-16T16:13:53Z
dc.date.created2022-10-19T01:01:51Z
dc.date.issued2017-08-22
dc.identifierhttps://doi.org/10.1002/pds.4275
dc.identifier1099-1557
dc.identifierhttp://hdl.handle.net/1843/46347
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/6681707
dc.publisherUniversidade Federal de Minas Gerais
dc.publisherBrasil
dc.publisherFAR - DEPARTAMENTO DE FARMÁCIA SOCIAL
dc.publisherUFMG
dc.relationInternational Conference on Pharmacoepidemiology & Therapeutic Risk Management
dc.rightsAcesso Aberto
dc.subjectArtrite reumatoide
dc.subjectDoença autoimune
dc.subjectMedicamentos
dc.titleCorticosteroid utilization and risk of infections among rheumatoid arthritis patients taking biologic and non-biologic disease modifying antirheumatic drugs
dc.typeArtigo de Evento


Este ítem pertenece a la siguiente institución